We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Top Buys

1
TSEM icon
Tower Semiconductor
TSEM
+$9.09M
2
LITE icon
Lumentum
LITE
+$8.24M
3
GLW icon
Corning
GLW
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

1
CNC icon
Centene
CNC
+$9.07M
2
MOH icon
Molina Healthcare
MOH
+$8.9M
3
ELV icon
Elevance Health
ELV
+$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PALI icon
126
Palisade Bio
PALI
$328M
$414K 0.15%
236,348
-179,687
-43% -$327K
VYGR icon
127
Voyager Therapeutics
VYGR
$184M
$413K 0.15%
+107,094
New +$422K
KOD icon
128
PUT
Kodiak Sciences
KOD
$2.58B
$411K 0.15%
+625
New +$16.1K
INCY icon
129
PUT
Incyte
INCY
$23.3B
$382K 0.14%
266
– –
COR icon
130
Cencora
COR
$59.9B
$382K 0.14%
1,216
+97
+9% +$33.9K
CMPX icon
131
Compass Therapeutics
CMPX
$378M
$382K 0.14%
72,193
+14,940
+26% +$86.2K
ICLR icon
132
Icon
ICLR
$13.1B
$378K 0.14%
3,413
+939
+38% +$128K
GH icon
133
Guardant Health
GH
$20.6B
$377K 0.14%
+4,086
New +$410K
SYK icon
134
Stryker
SYK
$127B
$365K 0.14%
1,110
+574
+107% +$206K
PRAX icon
135
Praxis Precision Medicines
PRAX
$8.59B
$364K 0.14%
1,131
-276
-20% -$85.4K
AR icon
136
Antero Resources
AR
$10.3B
$358K 0.13%
+8,101
New +$296K
RLMD icon
137
Relmada Therapeutics
RLMD
$573M
$353K 0.13%
50,773
-180,350
-78% -$853K
BIIB icon
138
Biogen
BIIB
$30.8B
$349K 0.13%
1,903
-971
-34% -$179K
QURE icon
139
PUT
uniQure
QURE
$2.71B
$345K 0.13%
688
– –
JCAP
140
Jefferson Capital
JCAP
$1.21B
$342K 0.13%
+17,775
New +$376K
NVO
141
PUT
Novo Nordisk
NVO
$228B
$339K 0.13%
143
– –
TRVI icon
142
Trevi Therapeutics
TRVI
$2.46B
$333K 0.12%
27,913
-17,917
-39% -$201K
MIRM icon
143
Mirum Pharmaceuticals
MIRM
$7.16B
$331K 0.12%
3,580
-6,609
-65% -$622K
ABVX
144
CALL
Abivax
ABVX
$12B
$325K 0.12%
+253
New +$29.9K
UMBF icon
145
UMB Financial
UMBF
$11.2B
$325K 0.12%
+2,879
New +$347K
PCVX icon
146
CALL
Vaxcyte
PCVX
$8.09B
$323K 0.12%
+135
New +$7.33K
PBF icon
147
PBF Energy
PBF
$7.21B
$323K 0.12%
+6,418
New +$240K
LIVN icon
148
LivaNova
LIVN
$4.49B
$318K 0.12%
5,004
+1,093
+28% +$70.5K
LOB icon
149
Live Oak Bancshares
LOB
$2.02B
$317K 0.12%
9,595
+4,919
+105% +$181K
EWTX icon
150
Edgewise Therapeutics
EWTX
$4.11B
$317K 0.12%
10,053
-11,151
-53% -$322K
4 5
6
7 8

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.